David A. Weinstein, M.D., M.Sc.Professor of Medicine
|M.D.||Harvard Medical School||Medicine|
|M.Sc.||Massachusetts Institute of Technology/Harvard Medical School||Clinical Investigation|
|Internship||Children's Hospital Boston||Pediatrics|
|Residency||Children's Hospital Boston||Pediatrics (Chief Resident, 1997-1998)|
|Fellowship||Children's Hospital Boston||Endrocrinology|
|Clinical Investigator||MIT/Harvard||Clinical Investigator Training Program|
|Name of Award/Honor||Awarding Organization|
|"Be My Sugar" Research Award||Congenital Hyperinsulinism International|
|Presidencia de Honor Award||Glucolatino, España|
|Lifetime Service Award||Association for Glycogen Storage Disease|
|Award for Dedication to the GSD Community (2014-2015)||Glucolatino Columbia|
|Amigo de las Glucogenosis Award||Asociación Española de Enfermos de Glucogenosis|
|Clinical Research Award||University of Florida College of Medicine|
|Inducted into Rare Disease Research Hall of Fame|
|Recipient of Order of the Smile Humanitarian Award (for Efforts to Help Children from Around the World)||Order Usmiechu in Poland|
|Jan Albrecht Award||American Association for the Study of Liver Diseases|
|Padrino de Honor||Fundacaion Glucolatino|
|George A. Sacher Award for Geriatric Research||Gerontological Society of America|
|Trinity College Alumni Award (Recognizing 5 Graduates for Excellence in Scholastic, Athletic, and Service Endeavors)||Trinity College|
|Barry M. Goldwater Scholarship Recipient for the State of Florida (Congressional Award Granted Annually to One Student per State Who Demonstrates “Outstanding Potential in the Fields of Mathematics and the Natural Sciences”)|
|Holland Scholar||Trinity College|
Dr. Weinstein specializes in disorders of carbohydrate metabolism with particular focus on glycogen storage disease (GSD), hypoglycemia, and diabetes. As the director of the Glycogen Storage Disease Program, he manages the inpatient and outpatient care for the largest cohort of GSD patients in the world following over 500 people with this disorder. Of these, over 225 patients have glycogen storage disease type Ia, 70 patients have glycogen storage disease type Ib, 50 patients have type III glycogen storage disease, and over 200 patients with types 0, VI, or IX GSD. His patients come from over 49 states and 43 countries to be cared for by him. Dr. Weinstein attends for the majority of glycogen storage disease inpatient evaluations along with 1-2 months per year on the inpatient endocrinology service.
|Name & Description||Category||Role||Type||Scope||Start Year||End Year|
|DSMB Member, New Drug Trial, Pfizer||Advisory Committee||Member||External||National||2005||2009|
|Association for Glycogen Storage Disease||Advisory Committee||Board of Directors||External||National||2002||2007|
Understanding the pathophysiology of hypoglycemia in children with a focus on the causes of ketotic hypoglycemia.
Investigation into the cause of morbidity type 0 and I glycogen storage disease including the pathophysiology of hepatic adenomas, hepatocellular carcinoma, nephrolithiasis, anemia, and focal segmental glomerulosclerosis.
Attempted methods of repairing the enzymatic defect in the glycogen storage diseases.